M&G PLC

Position in ONC — BeOne Medicines Ltd.

CIK 1802539 London, X0

Position in ONC

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$63,675,121

+$22,644,855 QoQ

Shares Held

223,445

+61.7% QoQ

Ownership

0.198%

of shares outstanding

% of Portfolio

0.33%

of 13F equity value

Holder Rank

#22

of 282 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

M&G PLC holds $116,189,172 across 10 Biotechnology names. ONC ranks #1 (54.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ONC	BeOne Medicines Ltd. This page	223,445	$63,675,121
2	AXSM	Axsome Therapeutics, Inc.	58,976	$14,435,555
3	BMRN	Biomarin Pharmaceutical Inc	216,096	$12,365,013
4	ALNY	Alnylam Pharmaceuticals, Inc.	35,912	$10,810,589
5	INSM	INSMED Inc	88,008	$9,383,412
6	BRNS	Barinthus Biotherapeutics plc.	5,197,349	$3,430,250
7	RVMD	Revolution Medicines, Inc.	4,296	$804,554
8	MESO	Mesoblast Ltd	59,100	$799,623

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$63,675,121	223,445	+61.7%	Shares	Defined	2026-08-06
2026-03-31	$41,030,266	138,163	+6.5%	Shares	Defined	2026-05-13
2025-12-31	$39,431,803	129,791	+7.5%	Shares	Defined	2026-02-12
2025-09-30	$41,129,644	120,721	-29.1%	Shares	Defined	2025-11-07
2025-06-30	$41,200,798	170,202	-8.5%	Shares	Sole	2025-08-08
2025-03-31	$50,632,057	186,031	-3.7%	Shares	Sole	2025-05-13
2024-12-31	$35,679,137	193,163	+11.6%	Shares	Sole	2025-02-11
2024-09-30	$38,857,068	173,075	-3.7%	Shares	Sole	2024-10-31
2024-06-30	$25,649,069	179,779	-5.4%	Shares	Sole	2024-07-16
2024-03-31	$29,722,857	190,056	—	Shares	Sole	2024-05-10
No filing history on record for this holder in this stock.